EHS
EHS

New patent expiration for APGDI drug MYRBETRIQ GRANULES – DrugPatentWatch


Copyright © DrugPatentWatch. Originally published at New patent expiration for APGDI drug MYRBETRIQ GRANULES


Annual Drug Patent Expirations for MYRBETRIQ+GRANULES

Myrbetriq Granules is a drug marketed by Apgdi and is included in one NDA. It is available from one supplier. There are four patents protecting this drug.

Drug patent litigation for MYRBETRIQ GRANULES.

The generic ingredient in MYRBETRIQ GRANULES is mirabegron. One supplier is listed for this compound. Additional details are available on the mirabegron profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent expiration for APGDI drug MYRBETRIQ GRANULES



Source link

EHS
Back to top button